Back to Agenda
Session 2: It’s all about Timely Access for Patients – How do we ensure they and other experts are heard?
Session Chair(s)
Valentina Strammiello, MA
Director of Programmes, European Patients' Forum, Belgium
Maggie Galbraith
, French National Authority for Health (HAS), France
The ultimate aim of the HTA regulation is to contribute to faster patient access. Patient and expert inclusion are prominently reflected in the legislative text, but as procedures are being developed, close engagement between all parties is needed to implement those elements as intended.
Speaker(s)
Setting the Scene: EMA’s Experience with Patient Engagement
Steffen Thirstrup, MD
Chief Medical Officer, European Medicines Agency, Netherlands
The EUnetHTA Perspective
Maggie Galbraith
, French National Authority for Health (HAS), France
Patient’s Perspective
Bettina Ryll
Member of the First EU Cancer Mission Board, MPNE, Vision Zero Cancer, Sweden
Clinical experts’ Perspective
Robin Doeswijk
Head of European Affairs, European Hematology Association, Netherlands
Have an account?